You have 9 free searches left this month | for more free features.

blinatumomab

Showing 1 - 25 of 59

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Immune Reconstitution After Allo-HSCT and Blinatumomab

Not yet recruiting
  • Leukemia, Lymphoid
  • blinatumomab
  • (no location specified)
Oct 3, 2023

Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

Recruiting
  • Leukemia, Lymphoid
  • blinatumomab
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Oct 27, 2023

Next-generation Sequencing in Pediatric B-ALL Children Patients

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • Blinatumomab
  • (no location specified)
Apr 19, 2023

Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

Not yet recruiting
  • Leukemia, Lymphoid
  • blinatumomab
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Oct 3, 2023

B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

Not yet recruiting
  • B Precursor Acute Lymphoblastic Leukemia
  • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
  • Blinatumomab
  • (no location specified)
Sep 25, 2023

Acute Lymphoblastic Leukemia Trial in Hangzhou (Blinatumomab)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Nov 5, 2023

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

Recruiting
  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  • Frankfurt, Germany
    Department of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023

Acute Lymphoblastic Leukemia Trial in Houston (Blinatumomab, Hematopoietic Cell Transplantation)

Completed
  • Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Hematopoietic Cell Transplantation
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 30, 2022

B Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Nov 1, 2022

Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive Trial in New York (Blinatumomab, dasatinib, dexamethasone)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Philadelphia Chromosome-Positive
  • Blinatumomab
  • +3 more
  • New York, New York
  • +1 more
Nov 10, 2022

Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 23, 2022

B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab, Conventional therapy)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Conventional therapy
  • Suzhou, Jiangsu, China
    The first affiliated hospital of Soochow University
Sep 26, 2022

Hematopoietic/Lymphoid Cancer, Richter's Transformation Trial in Houston (Blinatumomab, Dexamethasone)

Completed
  • Hematopoietic/Lymphoid Cancer
  • Richter's Transformation
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2022

B-cell Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Blinatumomab
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Apr 4, 2022

Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Blinatumomab
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
May 4, 2022

B-Cell Acute Lymphoblastic Leukemia, Adult Trial in La Jolla, Orange, San Francisco (blinatumomab, pembrolizumab)

Terminated
  • B-Cell Acute Lymphoblastic Leukemia, Adult
  • La Jolla, California
  • +2 more
Apr 26, 2022

B-Precursor ALL Trial in Germany (Blinatumomab)

Recruiting
  • B-Precursor ALL
  • Blinatumomab
  • Frankfurt (Main), Hessen, Germany
  • +20 more
Aug 16, 2022

Lymphoblastic Leukemia, Acute, Adult, Ph Negative ALL, Newly Diagnosed Trial in Czechia (Blinatumomab)

Active, not recruiting
  • Lymphoblastic Leukemia, Acute, Adult
  • +2 more
  • Blinatumomab
  • Brno, Czechia
  • +4 more
Aug 3, 2022

ALL, Recurrent, Adult Trial in Frankfurt (Main), Kiel (Blinatumomab, Venetoclax)

Recruiting
  • ALL, Recurrent, Adult
  • Frankfurt (Main), Hessen, Germany
  • +1 more
Jan 6, 2022

Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)

Not yet recruiting
  • Lymphoblastic Leukemia
  • Palo Alto, California
    Stanford University
Apr 27, 2023

Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia Trial in Japan (Blinatumomab)

Completed
  • Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Nagoya-shi, Aichi, Japan
  • +15 more
Dec 8, 2022

Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial (Blinatumomab)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • Mixed Phenotype Acute Leukemia
  • Blinatumomab
  • (no location specified)
Apr 7, 2022

Relapsed/Refractory Philadelphia Positive B-precursor ALL Trial in Worldwide (Blinatumomab)

Completed
  • Relapsed/Refractory Philadelphia Positive B-precursor ALL
  • Blinatumomab
  • Duarte, California
  • +21 more
Sep 8, 2022

ALL, Recurrent, Adult Trial in Germany (Blinatumomab)

Active, not recruiting
  • ALL, Recurrent, Adult
  • Blinatumomab
  • Frankfurt (Main), Hessen, Germany
  • +21 more
Mar 16, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022